[31-415-am] Molecular recognition

Sun. Mar 31, 2024 8:30 AM - 9:30 AM [Room 415] Conference Center 415 (4F)

Chair: Masahiro Anada, Shin Aoki

+Add all to schedule

8:30 AM - 8:42 AM

[31-415-am01S] Development of chloroalkene type peptidomimetics for amyloid-beta aggregation inhibitors

○Kenichi Yamamoto¹, Takuya Kobayakawa¹, Chika Azuma¹, Yuki Watanebe¹, Kohei Tsuji¹, Hirokazu Tamamura¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University)

8:42 AM - 8:54 AM

[31-415-am02S] Effect of synthesis conditions on the accuracy of enzymatic synthesis of oligonucleotides including a dual-modified nucleotide

○Kaito Nitatouge^1,2, Kenta Ishida^2,3, Hidekazu Hoshino², Yuuya Kasahara^2,3, Satoshi Obika^3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. Grad. Sch. Pharm. Sci., Osaka Univ. , 4. OTRI, Osaka Univ.)

8:54 AM - 9:06 AM

[31-415-am03S] Development of new membrane permeable oligonucleotide for nucleic acid therapeutics

○Hayato Yokoe¹, Fangjie Lyu¹, Hayase Hakariya¹, Haruka Hiraoka¹, Zhenmin Li¹, Noriaki Matsubara¹, Yonghao Soo¹, Fumitaka Hashiya², Naoko Abe¹, Zhaoma Shu¹, Kosuke Nakamoto¹, Yasuaki Kimura¹, Hiroshi Abe^1,3,4 (1. Grad. Sch. Sci., Nagoya Univ., 2. Res. Cen. Mat. Sci., Nagoya Univ., 3. JST-CREST, 4. iGCORE)

9:06 AM - 9:18 AM

[31-415-am04] Development of polymerases mutants applicable to bridged nucleic acids other than locked nucleic acid (LNA)

○Hidekazu Hoshino¹, Yuuya Kasahara^1,2, Satoshi Obika^1,2,3 (1. NIBIOHN, 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. OTRI, Osaka Univ.)

9:18 AM - 9:30 AM

[31-415-am05S] Creation of novel nucleic acid-based epigenetics therapeutics

○Soshu Yasuda¹, Kunihiko Morihiro¹, Akimitsu Okamoto¹ (1. Univ. of Tokyo)

Session information